Conclusion
This article has attempted to present some highlights from the rich economic literature pertaining to interventional cardiology and TAVI. There are currently more questions than answers, not surprisingly given the pace of technological change in interventional cardiology. For clinicians who work in a strictly regulated environment and have limited control over their use of medical technologies, this article will hopefully shed some light on the motives for policy decisions. For clinicians who make decisions on the resources used to treat their patients, we have aimed to provide the means of looking for evidence that will allow for informed decisions from both clinical and economic perspectives.